MoneyWorks4Me

Lupin informs about annual report

20 Jul 2020 Evaluate

In compliance with Regulation 34(1) of the Listing Regulations, Lupin has informed that it has enclosed the Annual Report of the Company for the year ended March 31, 2020, along with the Notice convening the Thirty-Eighth Annual General Meeting at 4.00 pm (IST) on Wednesday, August 12, 2020. The Annual Report contains information prescribed by Regulations 34(2) and (3) of the Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..